Pfizer eyes AstraZeneca for $100 billion acquisition

30th April 2014

After making a failed bid for AstraZeneca in January, pharmaceutical heavyweight Pfizer is again pursuing a deal for its British rival that would rank among the largest in industry history.

Pfizer (PFE, Fortune 500) said it made contact with AstraZeneca (AZN) on Saturday to renew acquisition discussions, the latest potential pairing in an industry gripped by a new wave of consolidation.

Read full article at source www.money.cnn.com


Leave a Reply

Your email address will not be published.

15 + = 22

« back to posts